Early Diagnosis, Pathogenesis and Treatment Strategies of Atrial Fibrillation
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 4844
Special Issue Editors
Interests: stroke; atrial fibrillation; public health; cardiovascular factors
Special Issue Information
Dear Colleagues,
Atrial fibrillation (AF) is a common cardiac arrhythmia, the treatment strategies for which vary depending on the underlying causes and severity of the condition.
This Special Issue will provide an overview of the pathogenesis of AF, and the complex interplay between various mechanisms involved in its initiation, early diagnosis, and management. This issue will also review the different strategies for detecting individuals at high risk for AF; the management and treatment of AF diagnosed early using methods such as artificial intelligence and digital devices; pharmacological therapies such as antiarrhythmic drugs and rate control agents; non-pharmacological interventions such as catheter ablation and electrical cardioversion; and stroke prevention strategies such as anticoagulation therapy. Moreover, we will discuss the challenges and limitations of early diagnosis, as well as current treatment options, and highlight emerging strategies that may offer new approaches to managing AF.
Dr. José-Luis Clúa-Espuny
Dr. Silvia Reverté-Villarroya
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atrial fibrillation
- diagnosis
- stroke
- cardioversion
- ablation
- cardiovascular risk
- secondary prevention
- artificial intelligence
- devices
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
